论文部分内容阅读
主要内容·概述·杂质控制理念的变迁·仿制药杂质研究的基本思路及方法·杂质研究的案例分析·杂质研究特别关注的问题概述·1、杂质的定义·2、杂质研究的地位·3、仿制药杂质研究的基本要求·4、存在的主要问题杂质的定义·任何影响药物纯度的物质统称为杂质.
仿制药的杂质研究
【摘 要】
：
主要内容·概述·杂质控制理念的变迁·仿制药杂质研究的基本思路及方法·杂质研究的案例分析·杂质研究特别关注的问题概述·1、杂质的定义·2、杂质研究的地位·3、仿制药
【出 处】
：
中国医药教育协会仿制药研发分析与变更要求及质量一致性评价研讨会
【发表日期】
：
2014年8期
其他文献
Although tissue engineering and regenerative medicine (TERM) is related to many subjects, the key factors in cellular products of TERM are cell-cell and cel
会议
Marrow derived adult Mesenchymal Stem Cells (MSCs) can be isolated and culture expanded.Although these cells are capable of differentiating into lineages th
会议
The Californian Institute for Regenerative Medicine (CIRM) has currently 77 research projects in translation to clinical trials and expects this to increase
会议
The field of biomaterials has been rapidly transitioning from inert or biodegradable matrices to bioactive structures designed rationally to interact and si
会议
ECM based products, either allogenic or xenogenic, have been widely used in soft tissues and hard tissues repair due to its biocompatibility and tissue-indu
会议
Organ transplantation is a victim of its own success.In view of the excellent results achieved to date, the demand for organs is escalating whereas the supp
会议
Our research has been focused on constructing a novel form of co-culture consisting layered tissue structure.We first developed unique tissue culture dishes
会议
Bringing Regenerative Medicine Products from Concept to Market Experiences from Advanced Tissue Scie
Cell-based products offer unique benefits in the areas of tissue and organ replacement and regeneration.These constructs are bio-interactive and respond to
会议
Mesoblastshas developed a platform technology and a commercial strategy based on the use of its unique proprietary population of mesenchymal precursor cells
会议